BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33507567)

  • 21. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
    Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
    Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats.
    Li T; Liu B; Li NS; Luo XJ; Peng JW; Peng J
    Life Sci; 2022 Oct; 307():120910. PubMed ID: 36029851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone Contributed to Pulmonary Arterial Hypertension Development via Stimulating Aquaporin Expression and Pulmonary Arterial Smooth Muscle Cells Proliferation.
    Wang Y; Zhong B; Wu Q; Zhu T; Wang Y; Zhang M
    Pharmacology; 2020; 105(7-8):405-415. PubMed ID: 31995798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
    Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
    Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
    J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
    Masson B; Saint-Martin Willer A; Dutheil M; Penalva L; Le Ribeuz H; El Jekmek K; Ruchon Y; Cohen-Kaminsky S; Sabourin J; Humbert M; Mercier O; Montani D; Capuano V; Antigny F
    Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L246-L261. PubMed ID: 37366608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease.
    Huang L; Li L; Yang T; Li W; Song L; Meng X; Gu Q; Xiong C; He J
    J Cell Mol Med; 2018 Dec; 22(12):6249-6261. PubMed ID: 30338626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 33. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Yamamura A; Nayeem MJ; Sato M
    Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway.
    Zhang W; Li Y; Xi X; Zhu G; Wang S; Liu Y; Song M
    Int J Mol Med; 2020 Feb; 45(2):461-474. PubMed ID: 31894295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.
    Su H; Zhu H; Wang S; Li Y; Yan C; Wang J; Ying K
    Respir Res; 2023 Jun; 24(1):165. PubMed ID: 37344798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDGF/MEK/ERK axis represses Ca
    Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
    Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 40. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
    Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
    J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.